South and Central America Genomics Market to 2027 - Regional Analysis and Forecasts By Technology (NGS, Sanger Sequencing, Microarray, PCR, Multiplex Ligation-dependent Probe Amplification (MLPA), and Other Technologies); Application (Diagnostics, Drug Discovery and Development, Precision/Personalized Medicine, Animal Research, Agriculture Research, and Others); End User (Research Centers, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Others) and Country
- THE3361266
- 141 Pages
- November 2019
- Diagnostic and Biotech
The growth of the genomics market is primarily attributed growth in technology developments in genomics rising investments & funds for genomics and development in the field of the agriculture and biotechnology. However, the market is likely to get impacted due to nonexistence of skilled professionals and high cost of equipment used in genomics are likely to pose a negative impact on the market growth. On the other hand, extensive use of genomics for medical applications is likely to have a positive impact on the growth of the South and Central America genomics market in the coming years.
Genomics is the field of science which deals in the production of whole genomes of organisms, and includes elements from genetics. Genomics uses a mixture of recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble, and analyze the structure and function of genomes. The large-scale Genome Centers will present the All of Us genomics platform. The genomics platform comprise achieving up to 200,000 genome-wide assays per year, generating high-quality genotyping and genome sequence data, and contributing to the advancement of technologies for population-scale genome analysis. Moreover, World Health Organization (WHO) to initiate almost US $1 million to launch the special program for research and Training in Tropical Diseases (TDR), which was the first broad genomic initiative involving Latin American countries. Thus, a good investments made by the government, companies is expected to increase the growth of the genomics market over the forecast years.
In 2018, the microarray segment held the largest market share in the genomics market, by technology. The microarray is expected to dominate its market share in 2027 owing to the microarrays have been widely used as single-nucleotide-polymorphism (SNP) genotyping platforms and the higher acceptance of the microarray in the field of genomics and wider applications. The next generation sequencing (NGS) segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027.
Research centers segment held the largest market share in the genomics market, by end user channel in 2018. This segment is also expected to dominate the market in 2027 owing research centers have developed various technologies in the field of the genomics and research centers provides researchers with references for further researches and this factor is likely to increase the market in the forecast period. Hospitals and clinics segment is also expected to grow at the fastest growth rate during the forecast period, 2019 to 2027.
Some of the major primary and secondary sources for genomic included in the report are Thermo Fisher Scientific Inc., Illumina Inc., Eurofins., Qiagen, Agilent Technologies, BGI, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, QIAGEN, Eurofins Scientific.Novo Nordisk a/s and others.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Genomics Market - By Technology
1.3.2 Genomics Market - By Application
1.3.3 Genomics Market - By End User
1.3.4 Genomics Market - By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Genomics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America PEST Analysis
4.3 Expert Opinions
5. Genomic Market - Key Industry Dynamics
5.1 Key Drivers
5.1.1 Growth in Investments & Funds for Genomics
5.1.2 Declining Cost of Sequencing Procedures
5.1.3 Technological Developments in Genomics
5.2 Key Restraints
5.2.1 Nonexistence of Skilled Professionals
5.2.2 High Cost of Equipment Used in Genomics
5.3 Key Opportunities
5.3.1 Scopes for the Consumer Genomics
5.3.2 Extensive Use of Genomics for Medical Applications
5.4 Future Trends
5.4.1 Technologies of Genomics
5.5 Impact Analysis
6. Genomics Market - Global Market Analysis
6.1 Global Genomics Market Revenue Forecasts And Analysis
7. Genomics Market -South and Central America Analysis
7.1 South and Central America Genomics Market Revenue Forecasts And Analysis
8. Genomics Market Analysis- By Technology
8.1 Overview
8.2 Genomics Market, By Technology 2018 & 2027 (%)
8.3 Next Generation Sequencing (NGS) Market
8.3.1 Overview
8.3.2 Next Generation Sequencing (NGS) Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Sanger Sequencing Market
8.4.1 Overview
8.4.2 Sanger Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Microarray Market
8.5.1 Overview
8.5.2 Microarray Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Polymerase Chain Reaction (PCR) Market
8.6.1 Overview
8.6.2 Polymerase Chain Reaction (PCR) Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Multiplex Ligation-dependent Probe Amplification (MLPA) Market
8.7.1 Overview
8.7.2 Multiplex Ligation-dependent Probe Amplification (MLPA) Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Other Technologies Market
8.8.1 Overview
8.8.2 Other Technologies Market Revenue and Forecasts to 2027 (US$ Mn)
9. Genomics Market Analysis- By Application
9.1 Overview
9.2 Genomics Market, By Application 2018 & 2027 (%)
9.3 Diagnostics Market
9.3.1 Overview
9.3.2 Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.3 Cardiogenetics Market
9.3.3.1 Overview
9.3.3.2 Cardiogenetics Market Revenue and Forecast to 2027 (US$ Mn)
9.3.4 Oncology Market
9.3.4.1 Overview
9.3.4.2 Oncology Market Revenue and Forecast to 2027 (US$ Mn)
9.3.4.3 Oncogenetics Market
9.3.4.3.1 Overview
9.3.4.3.2 Oncogenetics Market Revenue and Forecast to 2027 (US$ Mn)
9.3.4.4 OncoHemato Market
9.3.4.4.1 Overview
9.3.4.4.2 OncoHemato Market Revenue and Forecast to 2027 (US$ Mn)
9.3.5 Reproductive Disorders Market
9.3.5.1 Overview
9.3.5.2 Reproductive Disorders Market Revenue and Forecast to 2027 (US$ Mn)
9.3.6 Rare Diseases Market
9.3.6.1 Overview
9.3.6.2 Rare Diseases Market Revenue and Forecast to 2027 (US$ Mn)
9.3.7 Neurogenetics Market
9.3.7.1 Overview
9.3.7.2 Neurogenetics Market Revenue and Forecast to 2027 (US$ Mn)
9.3.8 Direct-to-Consumer Market
9.3.8.1 Overview
9.3.8.2 Direct-to-Consumer Market Revenue and Forecast to 2027 (US$ Mn)
9.3.9 Others Market
9.3.9.1 Overview
9.3.9.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Drug Discovery & Development Market
9.4.1 Overview
9.4.2 Drug Discovery & Development Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Precision/Personalized Medicine Market
9.5.1 Overview
9.5.2 Precision/Personalized Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Animal Research Market
9.6.1 Overview
9.6.2 Animal Research Market Revenue and Forecasts to 2027 (US$ Mn)
9.7 Agriculture Research Market
9.7.1 Overview
9.7.2 Agriculture Research Market Revenue and Forecasts to 2027 (US$ Mn)
9.8 Others Market
9.8.1 Overview
9.8.2 Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. Genomics Market Analysis- By End User
10.1 Overview
10.2 Genomics Market, By End User 2018 & 2027 (%)
10.3 Research Centers Market
10.3.1 Overview
10.3.2 Research Centers Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 Hospitals & Clinics Market
10.4.1 Overview
10.4.2 Hospitals and Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Pharmaceutical & Biotechnology Companies Market
10.5.1 Overview
10.5.2 Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)
10.6 Others Market
10.6.1 Overview
10.6.2 Others Market Revenue and Forecasts to 2027 (US$ Mn)
11. South And Central America Genomics Market Revenue And Forecasts To 2027
11.1.1 South and Central America Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.2 South and Central America Genomics Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
11.1.3 South and Central America Genomics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
11.1.3.1 South and Central America Diagnostic Market Revenue and Forecasts To 2027, By Diseases (US$ Mn)
11.1.3.1.1 South and Central America Oncology Market Revenue and Forecasts to 2027, By Type (US$ Mn)
11.1.4 South and Central America Genomics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.5 South and Central America Genomics Market Revenue and Forecasts to 2027, By Country (%)
11.1.6 Brazil Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.6.1 Brazil Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.6.2 Brazil Genomics Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
11.1.6.3 Brazil Genomics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
11.1.6.3.1 Brazil Diagnostic Market Revenue and Forecasts To 2027, By Diseases (US$ Mn)
11.1.6.3.1.1 Brazil Oncology Market Revenue and Forecasts to 2027, By Type (US$ Mn)
11.1.6.4 Brazil Genomics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.7 Argentina Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.7.1 Argentina Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.7.2 Argentina Genomics Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
11.1.7.3 Argentina Genomics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
11.1.7.3.1 Argentina Diagnostic Market Revenue and Forecasts To 2027, By Diseases (US$ Mn)
11.1.7.3.1.1 Argentina Oncology Market Revenue and Forecasts to 2027, By Type (US$ Mn)
11.1.7.4 Argentina Genomics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.8 Rest of South and Central America Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8.1 Rest of South and Central America Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8.2 Rest of South and Central America Genomics Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
11.1.8.3 Rest of South and Central America Genomics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
11.1.8.3.1 Rest of South and Central America Diagnostic Market Revenue and Forecasts To 2027, By Diseases (US$ Mn)
11.1.8.3.1.1 Rest of South and Central America Oncology Market Revenue and Forecasts to 2027, By Type (US$ Mn)
11.1.8.4 Rest of South and Central America Genomics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
12. Genomics Market -Industry Landscape
12.1 Overview
12.2 Growth Strategies done by the companies in the Market, 2018 (%)
12.3 Organic Growth Strategies
12.3.1 Overview
12.3.2 Product Launch
12.3.3 Approvals
12.3.4 Expansion
12.3.5 Product Expansion
12.3.6 Others
12.4 Inorganic Growth Strategies
12.4.1 Overview
12.4.2 Partnership
12.4.3 Acquisition
12.4.4 Collaboration
12.4.5 Agreement
13. Genomics Market-Key Company Profiles
13.1 F. Hoffmann-La Roche Ltd.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Financial Overview
13.1.4 Product Portfolio
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Agilent Technologies, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Financial Overview
13.2.4 Product Portfolio
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Danaher
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Financial Information
13.3.4 Product Portfolio
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Beijing Genomics Institute
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Financial Overview
13.4.4 Product Portfolio
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Mendelics Genomic Analysis SA
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Financial Overview
13.5.4 Product Portfolio
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Biosystems S.A.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Financial Overview
13.6.4 Product Portfolio
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Illumina, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 Product Portfolio
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Thermofisher Scientific Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Financial Overview
13.8.4 Product Portfolio
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 QIAGEN
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Financial Overview
13.9.4 Product Portfolio
13.9.5 Swot Analysis
13.9.6 Key Developments
13.10 Eurofins Scientific
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Financial Overview
13.10.4 Product/ Services Portfolio
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 THE IDENGENE
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Financial Information
13.11.4 Product Portfolio
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Argentine Bioinformatics platform (BIA)
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Financial Overview
13.12.4 Product Portfolio
13.12.5 Swot Analysis
13.12.6 Key Developments
13.13 DLE
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Financial Overview
13.13.4 Product Portfolio
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 DASA
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Financial Overview
13.14.4 Product Portfolio
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Fleury Genômica
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Financial Overview
13.15.4 Product Portfolio
13.15.5 SWOT Analysis
13.15.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary Of Terms
Table 1. Price of Various NGS Machines of some Major Players
Table 2. South and Central America Genomics Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 3. South and Central America Genomics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 4. South and Central America Diagnostic Market Revenue and Forecasts To 2027, By Diseases (US$ Mn)
Table 5. South and Central America Oncology Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 6. South and Central America Genomics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 7. Brazil Genomics Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 8. Brazil Genomics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 9. Brazil Diagnostic Market Revenue and Forecasts To 2027, By Diseases (US$ Mn)
Table 10. Brazil Oncology Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 11. Brazil Genomics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 12. Argentina Genomics Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 13. Argentina Genomics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 14. Argentina Diagnostic Market Revenue and Forecasts To 2027, By Diseases (US$ Mn)
Table 15. Argentina Oncology Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 16. Argentina Genomics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 17. Rest of South and Central America Genomics Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 18. Rest of South and Central America Genomics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 19. Rest of South and Central America Diagnostic Market Revenue and Forecasts To 2027, By Diseases (US$ Mn)
Table 20. Rest of South and Central America Oncology Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 21. Rest of South and Central America Genomics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 22. Recent Product Launch In The Genomics Market
Table 23. Product Approval In The Genomics Market
Table 24. Expansion Organic Growth Strategies In The Genomics Market
Table 25. Product Expansion Organic Growth Strategies In The Genomics Market
Table 26. Others Organic Growth Strategies In The Genomics Market
Table 27. Recent Partnership In The Genomics Market
Table 28. Recent Acquisition In The Genomics Market
Table 29. Recent Collaboration In The Genomics Market
Table 30. Recent Agreement In The Genomics Market
Table 31. Glossary of Terms, Colorectal Cancer Market
Similar Reports
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...
- Publish Date: February 7, 2017
- $750
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...
- Publish Date: February 7, 2017
- $750
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Con...
- Publish Date: February 7, 2017
- $750
